Article Information
History
- January 17, 2023.
Article Versions
- Version 1 (January 14, 2023 - 13:04).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Shuo Feng1,*,
- Julie McLellan2,
- Nicola Pidduck2,
- Nia Roberts3,
- Julian PT Higgins4,
- Yoon Choi5,
- Alane Izu6,
- Mark Jit7,
- Shabir A Madhi6,
- Kim Mulholland7,8,9,
- Andrew J Pollard1,10,
- Beth Temple7,8,9 and
- Merryn Voysey1,10,*
- 1Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
- 2Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
- 3Bodleian Health Care Libraries, University of Oxford, Oxford, UK
- 4Population Health Science, Bristol Medical School, University of Bristol, Bristol, UK
- 5Modelling and Economics Unit, UK Health Security Agency, London, UK
- 6South African Medical Research Council MRC Vaccines and Infectious Diseases Analytics Research Unit, Infectious Diseases and Oncology Research Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- 7Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK
- 8Murdoch Children’s Research Institute, Melbourne, VIC, Australia
- 9Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia
- 10NIHR Oxford Biomedical Research Centre, Oxford, UK
- ↵*Corresponding author:
Dr Shuo Feng: shuo.feng{at}paediatrics.ox.ac.uk, Prof Merryn Voysey: merryn.voysey{at}paediatrics.ox.ac.uk, Oxford Vaccine Group, Department of Paediatrics, University of Oxford, CCVTM, Churchill Road, Churchill Hospital, Oxford OX3 7LE United Kingdom